GEVO · Gevo, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.95M | - | $42.71M | $43.41M | $29.11M | - | $1.97M | $5.26M | $3.99M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $1.50M | - | $1.27M | $934.0K | $1.05M | - | $1.11M | $1.64M | $1.55M | - |
| SG&A | $16.21M | - | $11.65M | $10.78M | $11.08M | - | $11.68M | $11.51M | $12.15M | - |
| Total Operating Expenses | $47.85M | - | $46.40M | $37.62M | $49.25M | - | $25.97M | $29.29M | $27.13M | - |
| D&A | $6.86M | - | $7.40M | $7.21M | $5.62M | - | $3.49M | $4.75M | $4.45M | - |
| Operating Income | ($4.90M) | - | ($3.69M) | $5.80M | ($20.14M) | - | ($24.01M) | ($24.03M) | ($23.14M) | - |
| Interest Expense | $5.17M | - | $5.21M | $4.34M | $542.0K | - | $1.11M | $536.0K | $542.0K | - |
| Income Tax | $0 | - | - | - | $0 | - | - | - | $0 | - |
| Net Income | ($21.70M) | - | ($7.95M) | $2.14M | ($21.73M) | - | ($21.16M) | ($21.00M) | ($18.88M) | - |
| EPS - Basic | ($0.09) | - | ($0.03) | $0.01 | ($0.09) | - | ($0.09) | ($0.09) | ($0.08) | - |
| EPS - Diluted | ($0.09) | - | ($0.03) | $0.01 | ($0.09) | - | ($0.09) | ($0.09) | ($0.08) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78.90M | $81.16M | $72.60M | $57.26M | $65.29M | $189.39M | $223.23M | $245.68M | $270.64M | $298.35M |
| Accounts Receivable | $9.74M | $8.39M | $7.74M | $11.03M | $11.75M | $2.41M | $1.41M | $2.28M | $2.49M | $2.62M |
| Inventory | $21.59M | $19.08M | $21.91M | $16.94M | $16.79M | $4.50M | $5.85M | $3.44M | $3.76M | $3.81M |
| Accounts Payable | $5.54M | $1.08M | $3.19M | $7.57M | $5.61M | $539.0K | $1.61M | $1.69M | $3.60M | $2.72M |
| Current Assets | $115.87M | $143.40M | $136.71M | $170.44M | $103.86M | $203.71M | $236.63M | $258.11M | $282.30M | $386.38M |
| Total Assets | $653.50M | $718.93M | $685.21M | $702.12M | $677.80M | $583.94M | $603.79M | $617.91M | $633.57M | $650.32M |
| Current Liabilities | $26.89M | $78.58M | $71.66M | $73.23M | $51.00M | $24.36M | $28.67M | $25.25M | $22.06M | $91.43M |
| Long-term Debt | $166.75M | $164.75M | $134.19M | $139.60M | $147.09M | $67.11M | $66.90M | $66.70M | $68.16M | $21.0K |
| Total Liabilities | $198.80M | $247.76M | $210.38M | $222.35M | $203.01M | $94.45M | $99.07M | $95.17M | $91.63M | $92.93M |
| Stockholders' Equity | $447.75M | $466.34M | $468.87M | $474.10M | $469.84M | $489.49M | $504.72M | $522.74M | $541.95M | $557.39M |
| Retained Earnings | ($855.62M) | ($834.15M) | ($827.81M) | ($819.95M) | ($821.97M) | ($800.24M) | ($782.63M) | ($761.47M) | ($740.47M) | ($721.60M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($21.14M) | - | - | - | ($24.05M) | - | - | - | ($16.08M) | - |
| Investing Cash Flow | ($9.13M) | - | - | - | ($204.29M) | - | - | - | ($17.51M) | - |
| Financing Cash Flow | ($7.77M) | - | - | - | $104.24M | - | - | - | ($1.45M) | - |
| CapEx | $8.88M | - | - | - | $5.83M | - | $20.88M | $18.44M | $17.51M | - |
| Free Cash Flow | ($30.02M) | - | - | - | ($29.88M) | - | - | - | ($33.59M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -11.4% | - | -8.6% | 13.4% | -69.2% | - | -1221.8% | -456.8% | -580.0% | - |
| EBITDA margin | 4.6% | - | 8.7% | 30.0% | -49.9% | - | -1044.0% | -366.4% | -468.4% | - |
| Net margin | -50.5% | - | -18.6% | 4.9% | -74.6% | - | -1076.6% | -399.3% | -473.1% | - |
| Free cash flow margin | -69.9% | - | - | - | -102.7% | - | - | - | -841.9% | - |
| FCF / Net income | 1.38 | - | - | - | 1.38 | - | - | - | 1.78 | - |
| R&D / Revenue | 3.5% | - | 3.0% | 2.2% | 3.6% | - | 56.6% | 31.2% | 38.8% | - |
| SG&A / Revenue | 37.8% | - | 27.3% | 24.8% | 38.1% | - | 594.4% | 218.9% | 304.5% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -3.3% | - | -1.2% | 0.3% | -3.2% | - | -3.5% | -3.4% | -3.0% | - |
| Return on equity | -4.8% | - | -1.7% | 0.5% | -4.6% | - | -4.2% | -4.0% | -3.5% | - |
| Return on invested capital | -0.6% | - | - | - | -2.6% | - | - | - | -3.0% | - |
| Liquidity | ||||||||||
| Current ratio | 4.31 | 1.82 | 1.91 | 2.33 | 2.04 | 8.36 | 8.25 | 10.22 | 12.80 | 4.23 |
| Quick ratio | 3.51 | 1.58 | 1.60 | 2.10 | 1.71 | 8.18 | 8.05 | 10.09 | 12.62 | 4.18 |
| Cash ratio | 2.93 | 1.03 | 1.01 | 0.78 | 1.28 | 7.77 | 7.79 | 9.73 | 12.27 | 3.26 |
| Leverage | ||||||||||
| Debt / Equity | 0.37 | 0.35 | 0.29 | 0.29 | 0.31 | 0.14 | 0.13 | 0.13 | 0.13 | 0.00 |
| Debt / Assets | 0.26 | 0.23 | 0.20 | 0.20 | 0.22 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00 |
| Debt / EBITDA | 84.99 | - | 36.13 | 10.73 | - | - | - | - | - | - |
| Interest coverage | -0.9x | - | -0.7x | 1.3x | -37.2x | - | -21.7x | -44.8x | -42.7x | - |
| Equity multiplier | 1.46 | 1.54 | 1.46 | 1.48 | 1.44 | 1.19 | 1.20 | 1.18 | 1.17 | 1.17 |
| Liabilities / Assets | 0.30 | 0.34 | 0.31 | 0.32 | 0.30 | 0.16 | 0.16 | 0.15 | 0.14 | 0.14 |
| Efficiency | ||||||||||
| Asset turnover | 0.07 | - | 0.06 | 0.06 | 0.04 | - | 0.00 | 0.01 | 0.01 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 83d | - | 66d | 93d | 147d | - | 262d | 158d | 228d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | 132.0x | - | - | - | - | - | - |
| P / B | 1.4x | - | 1.0x | 0.7x | 0.6x | - | 0.8x | 0.3x | 0.3x | - |
| P / S | 15.1x | - | 10.7x | 7.2x | 9.2x | - | 198.6x | 25.4x | 46.5x | - |
| EV / EBITDA | 374.3x | - | 139.4x | 30.4x | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 47.5% | - | 2073.5% | 725.3% | 629.5% | - | -56.6% | 24.1% | -1.7% | - |
| Revenue CAGR (3y) | 119.5% | - | 417.0% | 400.6% | 400.6% | - | 140.1% | 131.9% | 250.1% | - |
| Revenue CAGR (5y) | 241.1% | - | 194.7% | 113.1% | 50.1% | - | -20.3% | 0.7% | -9.0% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 75.7% | - | 84.6% | - | 13.0% | - | -15.8% | -27.0% | -11.0% | - |
| Net income growth (YoY) | 0.1% | - | 62.4% | - | -15.1% | - | -34.8% | -45.6% | -7.1% | - |
| EPS growth (YoY) | 0.0% | - | 66.7% | - | -12.5% | - | -28.6% | -50.0% | -14.3% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -0.4% | - | - | - | 11.0% | - | - | - | -8.8% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -4.7% | -4.7% | -7.1% | -9.3% | -13.3% | -12.2% | -11.7% | -10.4% | -8.7% | -7.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$160.58M totalGevo North Dakota Segment$136.78M · 85.2%
Renewable Natural Gas Segment$18.05M · 11.2%
Gevo Segment$5.75M · 3.6%
Peer comparison
Same SIC group: Industrial Organic Chemicals
Comparing Gevo against the 5 most active filers in the same SIC group.